Coloplast A/S (OCSE:COLO B) Accounts Payable & Accrued Expense : kr5,037 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Coloplast A/S Accounts Payable & Accrued Expense?

Coloplast A/S's quarterly accounts payable & accrued expense increased from Sep. 2023 (kr8,772 Mil) to Dec. 2023 (kr9,385 Mil) but then declined from Dec. 2023 (kr9,385 Mil) to Mar. 2024 (kr5,037 Mil).

Coloplast A/S's annual accounts payable & accrued expense increased from Sep. 2021 (kr3,804 Mil) to Sep. 2022 (kr5,128 Mil) and increased from Sep. 2022 (kr5,128 Mil) to Sep. 2023 (kr8,772 Mil).

Coloplast A/S Accounts Payable & Accrued Expense Historical Data

The historical data trend for Coloplast A/S's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Accounts Payable & Accrued Expense Chart

Coloplast A/S Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3,647.00

3,481.00

3,804.00

5,128.00

8,772.00

Coloplast A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4,585.00	4,574.00	8,772.00	9,385.00	5,037.00

Coloplast A/S Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Coloplast A/S (OCSE:COLO B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OCSE:COLO B) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CLPBY:USA CLPBF:USA COLOBc:UK 0QBO:UK CBHD:Germany

Address

Holtedam 1-3, Humlebaek, DNK, DK-3050

Website

https://www.coloplast.com

Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (OCSE:COLO B) Headlines

No Headlines